Trump Administration Blasted For Promoting False Data On Medication Abortion Dangers

Two health officials from the Trump administration have cited a report from an anti-abortion organization during a Food and Drug Administration review of mifepristone, a medication used for abortion. This report claims to reveal a significantly elevated rate of severe side effects compared to previous findings; however, experts highlight its methodological flaws and the lack of data source transparency. Mifepristone, approved for abortion up to 10 weeks, is associated with rare serious complications, making up 63% of U.S. abortions in 2023, according to the Guttmacher Institute.Health Secretary Robert F. Kennedy Jr. labeled the report "alarming," suggesting it necessitates a labeling change for mifepristone. Reproductive health specialists argue that existing research demonstrating mifepristone’s safety contradicts the report's claims, citing longstanding, rigorous studies affirming its low rates of adverse events. Notably, the report's vague methodologies raise concerns about its credibility. Overall, comprehensive evaluations assure that mifepristone remains a safe option for medical abortion.